The nation of Zimbabwe has declined a significant American health deal worth $367m (£272m) over five years due to the United States' demand for confidential information.
The decision became public after a government memo dated December was leaked, revealing that President Emmerson Mnangagwa felt the deal was "lopsided".
A government representative later clarified that the US was requesting health data for scientific study and commercial gain but was not willing to share the benefits from future medical innovations.
"We are forced to start the difficult and regrettable task of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for further dialogue to reach a agreement acceptable to all parties so the country's critical HIV treatment initiative can proceed.
Wider Context
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a high court suspended a related health funding agreement after legal challenges were raised about the safety of citizens' medical information.
After resuming the presidency last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump claimed its spending was "wasteful" and his government was seeking direct bilateral deals to boost openness and responsibility.
According to statements, 16 nations in Africa have so far agreed to similar health pacts, representing over $18.3bn in new funding.
Details of the Declined Deal
The funds for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation could have provided immense benefits for Zimbabwean communities, especially the 1.2 million currently on antiretroviral therapy through US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, with no corresponding assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"In essence, our country would supply the basic resources for scientific discovery with no assurance that the end products would be available to our citizens should a new disease outbreak arise."
National Interest and Global Health
He also pointed out that the US's withdrawal from the global health body and its push of bilateral deals were disrupting structures already set up through the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage potential global health emergencies.
"This mechanism is intended to guarantee that when a country contributes its samples, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
The government's concerns over the US deal "are not meant as anti-American sentiment," he added.
"We are open to ongoing dialogue with our US partners on how future collaboration could be structured in a manner that respects the independence and interests of each country."
Health Experts Reaction
Medical experts expressed it recognised the government's concerns, but urged that negotiations should continue since much of the country's Aids initiatives depended on external financing.
"In cases where specific concerns arise, such as those relating to information security or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," it commented.
This impasse underscores the complex challenges between receiving crucial foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.